Detalhe da pesquisa
1.
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60.
J Neurol Neurosurg Psychiatry
; 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38453478
2.
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry.
J Neurol Neurosurg Psychiatry
; 2024 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38242680
3.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38569872
4.
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain
; 146(11): 4633-4644, 2023 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37369086
5.
Perspectives on Neuromyelitis Optica Spectrum Disorders, the Narrative Medicine contribution to care.
Neurol Sci
; 45(4): 1589-1597, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37919441
6.
Influence of cognition on the correlation between objective and subjective upper limb measures in people with multiple sclerosis.
Neurol Sci
; 45(6): 2783-2789, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38175316
7.
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning.
Neurol Sci
; 2024 Feb 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38388897
8.
Risk of secondary progressive multiple sclerosis after early worsening of disability.
J Neurol Neurosurg Psychiatry
; 94(12): 984-991, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37414538
9.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37068931
10.
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J Neurol Neurosurg Psychiatry
; 94(12): 1004-1011, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37414534
11.
Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study.
Mult Scler
; 29(14): 1808-1818, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37978852
12.
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Mult Scler
; 29(2): 221-235, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36433775
13.
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Mult Scler
; 29(7): 875-883, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36851894
14.
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult Scler
; 29(3): 326-332, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36800908
15.
Sars-CoV2 infection in pregnant women with multiple sclerosis.
Mult Scler
; 29(9): 1090-1098, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37232279
16.
Correlation between patient-reported manual ability and three objective measures of upper limb function in people with multiple sclerosis.
Eur J Neurol
; 30(1): 172-178, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36086993
17.
Relapse-associated worsening in a real-life multiple sclerosis cohort: the role of age and pyramidal phenotype.
Eur J Neurol
; 30(9): 2736-2744, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37294976
18.
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur J Neurol
; 30(4): 1014-1024, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36692895
19.
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
Brain
; 145(8): 2796-2805, 2022 08 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35325059
20.
Subclinical involvement of eye movements detected by video-based eye tracking in myasthenia gravis.
Neurol Sci
; 44(7): 2555-2559, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36971995